ArticleAging2020

Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell lines.

William H Chappell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.